US Pharma MarketingThe post Tandem secures CE mark for AID systems in T2D and T1D with pregnancy appeared first on Medical Device Network.
Tandem secures CE mark for AID systems in T2D and T1D with pregnancy
Tandem Diabetes Care has received a CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The regulatory clearance covers the t:slim X2 and Tandem Mobi insulin pumps with Control-IQ+ technology. The CIRCUIT trial assessed the t:slim X2 pump combined with Control-IQ technology. Credit: CottonCandyClouds / Shutterstock.com. Tandem Diabetes Care has received a CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The regulatory clearance covers the t:slim X2 and Tandem Mobi insulin pumps with Control-IQ+ technology, enabling their use for adults with type 2 diabetes (T2D) and for patients with…
Tandem Diabetes Care has received a CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe.
Source: Medical Device Network